FDG PET Scan in Lymphoma Management

Lymphoma is a type of cancer that develops in the lymphatic system, which plays a crucial part in the body's immune system. It also involves organs (spleen, bone marrow, liver, or other tissue) as well as lymph nodes. Lymphoma develops in various locations and acts differently in each type; therefore, it is vital that it is accurately assessed so that treatment and its response are planned for.

An FDG PET CT scan is one of the more sophisticated types of imaging exams that uses a combination of PET and CT scans. It gives information about the structure of tissues and about the metabolic activity of tissues. FDG PET CT has proven to be useful in the management of staging and response assessment in many FDG-avid lymphomas and is now an integral part of the recommended evaluation of the FDG lymphoma patient.

What Is an FDG PET CT Scan?

Fluorodeoxyglucose (FDG) PET CT is a low-dose scan that involves administering a radioactive dye that mimics glucose. The increased level of glucose consumption by many cancer cells helps to identify areas of elevated metabolism on a PET scan. The PET component shows increased metabolic activity, and the CT component shows the detail of anatomy. Putting these images together helps doctors determine where the lymphoma is, as well as how active the lymphoma is metabolically.

Why Is FDG PET CT Used in Lymphoma?

PET CT is not just used to detect enlarged lymph nodes in lymphoma. It gives information on how the distribution and metabolic activity of disease occurs inside the body. In FDG-avid lymphomas, PET CT is helpful in the initial staging process to help determine the extent of disease. It is also used as a measure of the effectiveness of treatment, especially following treatment. For FDG-avid lymphomas, the Lugano classification officially includes FDG PET CT as part of routine staging and response evaluation.

FDG PET CT for Lymphoma Staging

Staging is important to help the doctor understand the extent of the spread of lymphoma and plays a key role in treatment planning. An oncology PET CT scan is used to detect metabolically active lymphoma in various areas of the body, such as lymph nodes as well as in certain extranodal locations. It also gives information about involvement of other organs, such as the spleen or bone marrow, if applicable, based on the type and clinical condition of the lymphoma. PET CT is very useful for some non-Hodgkin lymphomas, especially for those that are aggressive or are FDG-avid, and in Hodgkin lymphoma. Not all lymphomas, however, behave in the identical manner on FDG PET; thus, the type of imaging depends on the type of lymphoma and clinical circumstances.

Role of FDG PET CT During Treatment

PET CT is also used to determine the response of the lymphoma to therapy. An interim PET CT scan is conducted during treatment in certain cases of lymphoma and treatment for the purposes of diagnosis. The results offer data on metabolic response and/or are part of the basis for treatment decisions in specific scenarios. Interim PET, however, shouldn't be routinely ordered or evaluated for each type of lymphoma. The time and usefulness vary with the type of disease and treatment protocol.

FDG PET CT After Treatment

An important use of an FDG PET CT scan is to assess response/activity at the end of treatment in many lymphomas that respond to immunotherapies such as chemotherapy and radiation therapy effectively. CT shows a swollen lymph node or mass that has been left over in the area from treatment that is not actually active and represents fibrosis or other changes. PET also offers other metabolic information which is useful in differentiating metastases from residual non-metabolic abnormalities. In lymphomas with FDG-avid tumours, the treatment response is routinely assessed by the Lugano classification and the Deauville 5-point scale.

What Is the Deauville Score?

To simplify the interpretation of FDG PET results in lymphoma, a score on a 5-point scale has been developed: the Deauville score. This compares the FDG uptake in regions of possible disease to an FDG uptake activity standard from normal tissue (such as blood pool and liver). This standardization is used to characterize the extent of response, residual activity, or persistent/progressive disease seen on the scan. When interpreting the score, it is essential to take the specific type of the patient's lymphoma, treatment history, symptoms, lab results, and previous imaging into account.

How Is an FDG PET CT Scan Performed?

The patient is given certain routine instructions beforehand, before the scan, such as fasting. Glucose levels are sometimes measured before administration of FDG due to the impact that the glucose level has on the distribution of the FDG. FDG is given for a short period, typically via an injection into the bloodstream. The patient is then placed in the rest position for a certain amount of time, permitting the tracer to passively diffuse throughout the body. The patient is then placed on a PET CT scanner for imaging and then removed. The acquisition of the CT usually takes place in the course of the same examination and is often followed or carried out together with the acquisition of the PET image. The technique used changes depending on patient condition and examination objectives.

What Does an FDG PET CT Scan Show in Lymphoma?

An FDG PET CT scan can provide information about the location and metabolic activity of lymphoma. Depending on the disease, it may help identify involved lymph nodes, extranodal disease, and areas that require further clinical evaluation. The scan can also be compared with previous PET CT examinations to assess changes in metabolic activity over time. This comparison can be particularly useful when evaluating treatment response. However, FDG uptake is not specific to cancer. Inflammation and infection can also show increased FDG uptake. Therefore, PET CT findings should be interpreted by an experienced specialist along with clinical and laboratory information.

FDG PET CT Scan Test Details

The exact FDG PET CT scan test details can vary depending on the patient's lymphoma subtype, treatment stage, medical history, and the purpose of the examination. Patients may be advised to avoid strenuous physical activity before the scan and follow fasting instructions provided by the imaging centre. Diabetic patients may require special preparation because blood glucose levels can influence FDG uptake. Patients should inform the medical team about diabetes, pregnancy or possible pregnancy, medications, previous reactions to contrast material, and other relevant medical conditions before the examination.

Is FDG PET CT Safe?

FDG PET CT involves exposure to radiation from both the radiotracer and the CT component. The amount is carefully considered against the clinical benefit of obtaining the necessary diagnostic information. The FDG used for PET imaging has a relatively short physical half-life and is gradually eliminated from the body. Patients are given specific instructions when necessary, particularly regarding hydration and urination after the examination. As with any medical imaging procedure, the decision to perform PET CT should be based on the patient's clinical requirements and the recommendation of the treating doctor.

FDG PET CT Scan Charges

The FDG PET CT scan charges can vary between diagnostic centres depending on the type of scan, imaging protocol, radiotracer used, location, and additional services included in the examination. Patients should confirm the current charges and preparation requirements directly with the diagnostic centre before scheduling the scan. It is also important to understand what is included in the quoted charges, particularly when additional CT contrast or specific imaging protocols are required.

Why Choose Molecular Diagnostics and Therapy for FDG PET CT?

Molecular Diagnostics and Therapy provides advanced nuclear medicine and diagnostic imaging services to support cancer evaluation and treatment monitoring. For patients undergoing lymphoma assessment, an FDG PET CT scan can provide valuable metabolic and anatomical information when clinically indicated. The scan should be performed according to the referring doctor's requirements, with interpretation by qualified specialists. Using advanced PET CT technology and standardized approaches to lymphoma response assessment can help provide clinically useful information for oncologists and other treating specialists.

Conclusion

In the treatment of various FDG-avid lymphomas, FDG PET CT is emerging as a very valuable imaging modality. It is useful for early staging, treatment response, and post-treatment evaluation. PET images are interpreted with greater uniformity by standardized systems like the Lugano classification or five-point Deauville scale. But PET CT is just one component of lymphoma treatment. The results should be evaluated in conjunction with biopsy results, clinical exam, lab work, past treatments, and other imaging modalities. 

The timing and frequency of PET CT are dependent on both the type of lymphoma and the treatment plan of each person.Molecular Diagnostics and Therapy provides state-of-the-art diagnostics and nuclear medicine services to complement a comprehensive oncology evaluation. Before scheduling your scan, discuss with the medical team the best scan protocol well suited for your lymphoma and how to prepare for the scan.